drugset / Trial / NCT05890638
Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to compare the acute bronchodilator effect of the Ipratropium / Levosalbutamol 1.25 mg \& 0.5 mg / 2.5 mL fixed dose combination nebuliser solution or Levosalbutamol 1.25 mg / 3 mL nebuliser solution and Ipratropium 500 mcg nebuliser solution in stable moderate-severe-very severe COPD patients.
Timeline
- Start
- 2023-08-25
- Primary completion
- 2024-02-06
- Completion
- 2024-03-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ipratropium | Small molecule | 500 ug | Inhaled |
| Subject | Ipratropium | Small molecule | 1.25 mg | Inhaled |
| Subject | Levalbuterol | Other / unclassified | 0.5 mg | Inhaled |
| Subject | Levalbuterol | Other / unclassified | 1.25 mg | Inhaled |